Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying the miR Fingerprint in NAF, Serum, and Tissue in Patients With Ductal Carcinoma in Situ (DCIS) or Invasive Breast Cancer

NCT02127073 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.

NCT NCT02127073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02127073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying the miR Fingerprint in NAF, Serum, and Tissue in Patients With Ductal Carcinoma in Situ (DCIS) or Invasive Breast Cancer
Lead sponsor
Montefiore Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
January 30, 2015
Completion date
September 18, 2017
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, ductal carcinoma in situ